1. Fabricant DS and Farnsworth NR: The value of plants used in tradi- tional medicine for drug discovery. Environ Health Perspect 109 Suppl 1: 69-75, 2001.
2. Hamilton GR and Baskett TF: In the arms of Morpheus the develop- ment of morphine for postoperative pain relief. Canadian journal of anaesthesia = Journal canadien d'anesthesie 47: 367-374, 2000.
3. Wood TB, Spivey WTN and Easterfield TH: Cannabinol. Part I. J Chem Soc 75: 20–36, 1899.
4. Adams R: Marihuana. Harvey Lectures. 37 168–197: 1941–1942.
5. Cahn RS: Cannabis indica resin, Part, III The constitution of Cannabinol. J Chem Soc 1342–1353, 1932.
6. Mechoulam R and Shvo Y: Hashish. I. The structure of cannabidiol. Tetrahedron 19: 2073-2078, 1963.
7. Gaoni Y and Mechoulam R: Isolation, Structure, and Partial Synthesis of an Active Constituent of Hashish. Journal of the American Chemical Society 86: 1646-1647, 1964.
8. Devane WA, Dysarz FA, 3rd, Johnson MR, Melvin LS and Howlett AC: Determination and characterization of a cannabinoid receptor in rat brain. Molecular pharmacology 34: 605-613, 1988.
9. Matsuda LA, Lolait SJ, Brownstein MJ, Young AC and Bonner TI: Struc- tre of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346: 561-564, 1990.
10. Devane WA, Hanus L, Breuer A, et al: Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science (New York, NY) 258: 1946-1949, 1992.
11. Munro S, Thomas KL and Abu-Shaar M: Molecular characterization of a peripheral receptor for cannabinoids. Nature 365: 61-65, 1993.
12. Mechoulam R, Ben-Shabat S, Hanus L, et al: Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to canna- binoid receptors. Biochem Pharmacol 50: 83-90, 1995.
13. Sugiura T, Kondo S, Sukagawa A, et al: 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain. Biochemical and biophysical research communications 215: 89-97, 1995.